GRAY WILLIAM GARRETT

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 77% 68% 82%
Transactions
15 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GRAY WILLIAM GARRETT's trades of Checkpoint Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-03 2025-04-01
S Sale
66,455 +31.2%
154.36
US$1,700,838 		66,455 +31.2% 154.36 US$1,700,838
2025-02-07 2025-02-06
S Sale
56,190 -15.9%
297.14
US$875,874 		56,190 -15.9% 297.14 US$875,874
2024-12-20 2024-12-18
S Sale
19,440 +35.7%
137.10
US$3,008,930 		19,440 +35.7% 137.10 US$3,008,930
2024-06-28 2024-06-26
S Sale
13,038 -1.9%
2.06
US$26,858 		13,038 -1.9% 2.06 US$26,858
2024-03-01 2024-02-28
S Sale
2,035 -1.4%
2.07
US$4,212 		2,035 -1.4% 2.07 US$4,212
2024-02-02 2024-02-01
S Sale
4,115 -2.7%
1.95
US$8,024 		4,115 -2.7% 1.95 US$8,024
2023-03-03 2023-03-02
S Sale
3,591 -6.5%
5.00
US$17,955 		3,591 -6.5% 5.00 US$17,955
2023-03-03 2023-02-27
S Sale
1,914 -3.9%
4.66
US$8,919 		1,914 -3.9% 4.66 US$8,919
2023-02-03 2023-02-01
S Sale
3,154 -6.0%
4.79
US$15,108 		3,154 -6.0% 4.79 US$15,108
2023-01-12 2023-01-10
S Sale
1,858 -3.4%
6.75
US$12,540 		1,858 -3.4% 6.75 US$12,540
2022-03-11 2022-03-10
S Sale
38,197 -6.6%
1.89
US$72,307 		38,197 -6.6% 1.89 US$72,307
2022-02-02 2022-02-01
S Sale
37,063 -6.0%
2.51
US$92,954 		37,063 -6.0% 2.51 US$92,954
2021-02-05 2021-02-04
S Sale
26,320 -5.2%
3.66
US$96,318 		26,320 -5.2% 3.66 US$96,318
2020-12-23 2020-12-22
S Sale
2,406 -0.7%
2.79
US$6,712 		2,406 -0.7% 2.79 US$6,712
2020-05-22 2020-05-21
S Sale
17,104 -4.5%
2.00
US$34,122 		17,104 -4.5% 2.00 US$34,122